| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |